David Najman to Hypolipidemic Agents
This is a "connection" page, showing publications David Najman has written about Hypolipidemic Agents.
Connection Strength
0.255
-
Adverse events related to muraglitazar use in diabetes. JAMA. 2006 May 03; 295(17):1997; author reply 1998.
Score: 0.255
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.